Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950142-23-001715
Filing Date
2023-06-15
Accepted
2023-06-15 17:17:58
Documents
1
Group Members
GA IMC HOLDING, L.P.GA IMC HOLDING, LTD.GAP (BERMUDA) L.P.GAP COINVESTMENTS CDA, L.P.GAP COINVESTMENTS III, LLCGAP COINVESTMENTS IV, LLCGAP COINVESTMENTS V, LLCGENERAL ATLANTIC (LUX) S.A R.L.GENERAL ATLANTIC GENPAR (BERMUDA), L.P.GENERAL ATLANTIC GENPAR (

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 eh230370275_13da4-imcr.htm SC 13D/A 264675
  Complete submission text file 0000950142-23-001715.txt   267279
Mailing Address 55 EAST 52ND STREET 33RD FLOOR NEW YORK NY 10055
Business Address 55 EAST 52ND STREET 33RD FLOOR NEW YORK NY 10055 212 715 4000
GENERAL ATLANTIC, L.P. (Filed by) CIK: 0001017645 (see all company filings)

EIN.: 133503735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Subject) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92246 | Film No.: 231018479
SIC: 2836 Biological Products, (No Diagnostic Substances)